A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell Lymphoma
Source check: Source checked. Not independent scientific confirmation.
Finding: A deep-learning method automated metabolic-tumor-volume measurement in diffuse large B-cell lymphoma PET/CT and was compared with expert reader assessment. This record is limited to the study result and does not establish independent replication or real-world benefit.
Technology: Deep-learning tumor-volume segmentation
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Methods describe semiautomated reader reference and trial cohort; Results assess automated MTV measurement in 100 DLBCL patients.
- Test and result
- A deep-learning method automated metabolic-tumor-volume measurement in diffuse large B-cell lymphoma PET/CT and was compared with expert reader assessment.
- Limitation / still unknown
- The source-checked evidence does not establish broader external validity or prospective benefit. Affiliation was not available in the retrieved trusted primary metadata. Organization affiliation was not stated in the source material reviewed. Affiliation was not stated in the reviewed material.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9653575/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.